TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ALKS

Alkermes Plc

Healthcare · Drug Manufacturers - Specialty & Generic

41.80$ +3.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Alkermes Plc (ALKS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 4,393 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ALKS
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,707 1,726 1,730 1,731 1,748 1,797 1,737 1,751 1,761 1,825 1,757 1,752 1,758 1,805 1,826 1,802 1,877 1,950 1,878 1,938 1,995 2,024 1,978 1,957 1,942 1,964 1,923 2,187 2,279 2,136 2,124 2,207 2,155 2,056 2,082 2,253 2,330 2,530 4,258 4,393
807 913 759 796 782 966 914 840 870 983 1,006 995 998 962 913 947 1,025 1,111 1,006 1,038 1,053 1,062 1,015 1,046 1,054 1,130 1,110 1,397 1,465 1,486 1,469 1,542 1,564 1,415 1,479 1,635 1,742 1,929 1,359 1,523
202 186 181 158 165 191 187 156 216 267 225 196 261 204 176 189 241 273 205 258 310 338 283 255 264 292 321 666 648 457 421 535 396 291 400 521 616 1,120 352 512
549 619 476 475 450 591 542 434 467 539 625 570 587 535 496 533 569 635 541 538 560 536 529 581 580 608 600 829 889 773 745 876 909 752 884 1,016 1,111 1,319 512 657
177 191 176 200 208 234 240 270 264 300 231 274 255 265 261 247 280 290 253 306 293 327 270 262 267 297 278 334 340 333 317 370 370 390 322 355 355 334 408 456
54 63 64 77 85 93 85 87 88 90 93 95 101 102 109 116 123 126 134 136 139 150 155 156 166 181 185 189 192 186 198 195 191 183 183 192 191 197 337 299
262 265 265 266 271 285 290 297 303 310 320 326 341 362 363 362 355 350 346 467 341 341 337 337 326 325 321 – 431 – – – – – – – – – – –
93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 83 93 93 93 83 83 83 83 83 – – – 84 596 594
334 318 303 287 272 256 240 224 207 191 181 171 161 151 141 131 121 111 102 93 84 74 65 56 47 38 29 20 11 2.0 0.9 0.9 0.9 0.9 84 84 84 84 1,784 1,761
498 517 513 529 561 594 581 593 610 654 654 661 690 720 763 740 792 883 827 840 899 912 902 875 899 920 917 907 924 934 869 923 863 591 570 628 596 711 2,507 2,585
190 212 211 225 256 291 275 287 305 340 328 334 370 391 340 321 378 438 366 383 453 471 462 439 470 498 493 487 503 520 459 516 454 465 444 506 474 543 599 662
3.0 3.0 3.0 3.0 3.0 3.0 2.8 2.8 2.8 2.8 12 20 20 11 36 33 30 19 35 35 19 19 35 35 35 13 18 18 18 8.7 8.9 9.0 9.2 6.2 6.3 6.5 6.6 6.7 34 34
44 46 57 55 53 56 65 58 44 40 49 43 81 54 43 51 83 46 36 33 37 56 28 40 33 33 37 85 87 66 77 105 37 46 60 99 68 108 102 143
283 281 280 280 279 278 278 278 277 276 276 275 275 274 274 273 273 272 295 294 293 293 292 292 291 290 290 289 288 288 287 286 286 – – – – – 1,484 –
1,210 1,209 1,217 1,202 1,187 1,203 1,156 1,158 1,151 1,171 1,102 1,091 1,068 1,085 1,063 1,062 1,084 1,067 1,051 1,098 1,096 1,113 1,075 1,082 1,043 1,044 1,006 1,280 1,356 1,203 1,255 1,284 1,292 1,465 1,512 1,625 1,733 1,819 1,752 1,809
-927 -948 -955 -998 -1,035 -1,044 -1,109 -1,141 -1,176 -1,185 -1,282 -1,324 -1,377 -1,382 -1,421 -1,450 -1,450 -1,493 -1,515 -1,513 -1,542 -1,541 -1,577 -1,607 -1,671 -1,699 -1,741 -1,504 -1,456 -1,344 -1,307 -1,215 -1,123 -976 -954 -867 -784 -735 -801 -801
152 152 153 153 154 154 154 155 155 156 156 157 157 158 158 159 159 159 160 164 161 162 162 164 164 164 165 172 172 170 173 171 167 167 169 168 169 169 166 167

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?